Hannah Joseph

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE0JVH01012
  • NSEID:
  • BSEID: 544687
INR
111.00
0.15 (0.14%)
BSENSE

Sep 21, 04:01 PM

BSE+NSE Vol: 32000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

32.0 k (35.59%) Volume

Shareholding (Feb 2026)

FII

2.39%

Held by 2 FIIs

DII

10.15%

Held by 0 DIIs

Promoter

68.83%

Which are the latest news on Hannah Joseph?

21-Sep-2026
No latest news for Hannah Joseph found.

Why is Hannah Joseph Hospital Ltd falling/rising?

06-Sep-2026

As of 05-Sep, the stock price of Hannah Joseph Hospital Ltd is declining, currently at 114.60, reflecting a decrease of 2.88%. This follows a trend reversal after two days of gains, with decreased investor participation and short-term weakness indicated by its position relative to moving averages.

As of 05-Sep, the stock price of Hannah Joseph Hospital Ltd is falling, currently at 114.60, which reflects a decrease of 3.4 or 2.88%. This decline follows a trend reversal after two consecutive days of gains. Additionally, the stock has underperformed its sector by 1.62% today. It reached an intraday low of Rs 114.2, marking a drop of 3.22%. <BR><BR>Investor participation has also decreased, with delivery volume on September 3 falling by 70.59% compared to the 5-day average. Although the stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, it is below its 5-day moving average, indicating a short-term weakness. Overall, these factors contribute to the current decline in the stock price.

View full answer

Who are the peers of the Hannah Joseph?

01-Sep-2026

Hannah Joseph's peers include GPT Healthcare, Asarfi Hospital, Lotus Eye Hospital, Aashka Hospitals, Aprameya Enginee, Chandan Healthcare, Unihealth Hospital, Vaidya Sane, and Nephro Care. Asarfi Hospital has the highest 1-year return at 77.75%, while Lotus Eye Hospital has the lowest at -6.51%.

Peers: The peers of Hannah Joseph are GPT Healthcare, Asarfi Hospital, Lotus Eye Hospit, Aashka Hospitals, Aprameya Enginee, Chandan Healthca, Unihealth Hosp, Vaidya Sane, and Nephro Care.<BR><BR>Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Aprameya Enginee, while Average management risk is found at Asarfi Hospital, Chandan Healthca, Unihealth Hosp, and Nephro Care. Below Average management risk is noted at Lotus Eye Hospit, Aashka Hospitals, and Vaidya Sane, and the rest. Growth is Excellent at Chandan Healthca, Unihealth Hosp, and Nephro Care, while Good growth is seen at Asarfi Hospital, and the rest. Below Average growth is present at GPT Healthcare, Lotus Eye Hospit, Aashka Hospitals, and the rest. Capital Structure is Excellent at GPT Healthcare and Unihealth Hosp, Good at Asarfi Hospital, Aprameya Enginee, Chandan Healthca, and Vaidya Sane, Average at Aashka Hospitals, and Below Average at Lotus Eye Hospit.<BR><BR>Return Snapshot: Asarfi Hospital has the highest 1-year return at 77.75%, while Lotus Eye Hospit has the lowest at -6.51%, with Hannah Joseph's return not available for comparison. Additionally, Aashka Hospitals and Aprameya Enginee have negative six-month returns.

View full answer

How big is Hannah Joseph?

01-Sep-2026

As of 31st August, Hannah Joseph Hospital Ltd has a market capitalization of 262.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales or Net Profit for the latest four quarters. As of March 2026, Shareholder's Funds are 97.37 Cr and Total Assets are 133.00 Cr.

As of 31st August, <BR><BR>Market Cap: Hannah Joseph Hospital Ltd has a market capitalization of 262.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2026, with Shareholder's Funds amounting to 97.37 Cr and Total Assets totaling 133.00 Cr.

View full answer

What does Hannah Joseph do?

14-Aug-2026

Hannah Joseph Hospital Ltd is a micro-cap company in the hospital industry, focusing on neurosurgery and neurology services, established in 2008 in Madurai, Tamil Nadu. It has a market cap of INR 245 Cr, with no recent revenue or profit data available.

Overview: <BR>Hannah Joseph Hospital Ltd is a micro-cap company in the hospital industry, specializing in neurosurgery and neurology services, and is one of the first centers in Asia to adopt DTI Fibertracking 3.0 for brain tumor surgeries.<BR><BR>History: <BR>Hannah Joseph Hospital was established in 2008 as a sole proprietorship by Mosesjoseph Arunkumar in Madurai, Tamil Nadu. There are no reported status changes, and revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 245 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 23.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 1.85% <BR>Debt-Equity: -0.17 <BR>Return on Equity: 11.48% <BR>Price-to-Book: 2.52 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

View full answer

When is the next results date for Hannah Joseph Hospital Ltd?

19-May-2026

The next results date for Hannah Joseph Hospital Ltd is 29 May 2026.

The next results date for Hannah Joseph Hospital Ltd is scheduled for 29 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 254 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.80%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

11.48%

stock-summary
Price to Book

2.59

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.8%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.32%
2.01%
16.33%
6 Months
87.5%
3.45%
90.95%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 2 per share ex-dividend date: Jul-08-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Award

09-Sep-2026 | Source : BSE

We are pleased to inform you that Hannah Joseph Hospital Limited has been recognized as the "Winner" in the category of "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation Awards 2026 organized by the Confederation of Indian Industry (CII).

Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Award

01-Sep-2026 | Source : BSE

We are pleased to inform you that Hannah Joseph Hospital Limited Madurai has been conferred with the "AHPI-TN Excellence Award 2026 - Best Single Hospital above 100 beds - Central Zone" by the Association of Healthcare Providers of India (AHPI) Tamil Nadu Chapter.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

11-Aug-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Daniel Dayanand Fenn & PACs

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Hannah Joseph Hospital Ltd has declared 20% dividend, ex-date: 08 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
4.09
Debt to EBITDA (avg)
1.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.81
Tax Ratio
30.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.54%
ROCE (avg)
20.09%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
0
Price to Book Value
2.59
EV to EBIT
12.80
EV to EBITDA
9.37
EV to Capital Employed
2.91
EV to Sales
2.57
PEG Ratio
NA
Dividend Yield
1.80%
ROCE (Latest)
22.75%
ROE (Latest)
11.48%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bearish
Bollinger Bands
Sideways
KST
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (2.39%)

Promoter with highest holding

Mosesjoseph Arunkumar . (66.8%)

Highest Public shareholder

Negen Undiscovered Value Fund (3.68%)

Individual Investors Holdings

15.79%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Hannah Joseph"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 16.36% vs 15.00% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 18.36% vs 64.10% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "49.51",
          "val2": "42.55",
          "chgp": "16.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.45",
          "val2": "11.76",
          "chgp": "14.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.36",
          "val2": "1.56",
          "chgp": "-12.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.06",
          "val2": "5.12",
          "chgp": "18.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.17%",
          "val2": "27.64%",
          "chgp": "-0.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Hannah Joseph"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 18.73% vs 22.27% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 55.06% vs 77.15% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "92.05",
          "val2": "77.53",
          "chgp": "18.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.20",
          "val2": "20.69",
          "chgp": "21.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.92",
          "val2": "3.47",
          "chgp": "-15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.18",
          "val2": "7.21",
          "chgp": "55.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.38%",
          "val2": "26.69%",
          "chgp": "0.69%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
49.51
42.55
16.36%
Operating Profit (PBDIT) excl Other Income
13.45
11.76
14.37%
Interest
1.36
1.56
-12.82%
Exceptional Items
0.00
0.00
Standalone Net Profit
6.06
5.12
18.36%
Operating Profit Margin (Excl OI)
27.17%
27.64%
-0.47%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 16.36% vs 15.00% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 18.36% vs 64.10% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
92.05
77.53
18.73%
Operating Profit (PBDIT) excl Other Income
25.20
20.69
21.80%
Interest
2.92
3.47
-15.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
11.18
7.21
55.06%
Operating Profit Margin (Excl OI)
27.38%
26.69%
0.69%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 18.73% vs 22.27% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 55.06% vs 77.15% in Mar 2025

stock-summaryCompany CV
About Hannah Joseph Hospital Ltd stock-summary
stock-summary
Hannah Joseph Hospital Ltd
Micro Cap
Hospital
Hannah Joseph Hospital Limited is one of the first centres in Asia to adopt DTI Fibertracking 3.0, a revolutionary navigation tool for brain tumour surgeries. To provide comprehensive range of neurosurgery and neurology services, Mosesjoseph Arunkumar established a hospital in the name of `Hannah Joseph Hospital' as a sole proprietorship in Madurai town of Tamil Nadu, in 2008.
Company Coordinates stock-summary
Icon
No Company Details Available